FMI estimates that the patient-reported outcome data monetization market was valued at USD 1.2 Billion in 2025. Revenue is set to reach USD 1.3 Billion in 2026 and USD 4.0 Billion by 2036. Clinical PROs segment is anticipated to lead among the data type segments with 38.5% share in 2026, supported by regulatory mandates for objective symptom baseline metrics. The data licensing segment is likely to lead among the monetization model segments through 2036.